Introduction
A new class of tumor suppressor genes (TSGs), with haploid insufficiency, in which one allele is lost and the remaining allele is haploinsufficient, has been described recently, and these hemizygous tumor suppressor genes show a tumor-prone phenotype when challenged with carcinogens 1 . One of the critical steps for the identification of TSGs is loss of heterozygosity analysis (LOH) . By this method, we previously showed ING1 and ING3 as a class 2 TSGs in head and neck squamous cell carcinomas (HNSCC) 2, 3) . Both ING1 and ING3, which belong to ING family genes are rarely mutated but reveal a high allelic deletion rate. Chromosome 12p12-13 region has also known to be deleted in various cancers including hematological malignancies, breast cancer, prostate cancer, non-small cell lung cancer and nasopharyngeal carcinomas. Since it's been shown some of the ING family members functioning as TSG, it is likely that other members of this family could be a TSG. ING4, a new member of ING family, was localized to this frequently deleted region of 12p13.31.
In the current study, we examined the ING4 locus for allelic deletion in HNSCC. We also analyzed mutation and mRNA expression level of ING4 in HNSCC.
Materials and methods

Tissue samples
Paired normal and tumor samples were obtained from 50 patients with primary HNSCC at the department of otolaryngology, Okayama University Hospital after acquisition of informed consent from each patient. Submandibular gland or muscle far and free from tumor invasion was obtained as normal control in our experiments. All tissues were frozen in liquid nitrogen immediately after surgery and stored -80°C until the extraction of DNA and RNA. Histological studies were also performed at the department of pathology, and all tumors were confirmed as squamous cell carcinoma.
DNA and RNA extractions
DNA and RNA extractions were performed as described in detail elsewhere 2, 3) .
Microsatellite analysis
Primers for amplification of microsatellite markers D12S372, D12S825, D12S77, D12S1697, D12S89 and D12S391 are available through the internet genome database (http:// www.gdb.org). PCR amplification and silver staining were performed as described previously 2, 3) .
Real time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR)
Real time quantitative RT-PCR was performed as described previously 2, 3) . The value of tumor specific ING4 expression was determined by calculating the ratio of the expression level in the tumor and that in the matched normal sample, each of which was normalized for the corresponding Cyclophilin expression level (T: ING4/Cyclophilin expression ratio in tumor sample; N: ING4/ Cyclophilin expression ratio in matched normal sample; T/N ratio was the relative ING4 expression in tumor sample). Decreased and increased expression levels were defined when this ratio was ≤ 0.75 (25% or more decrease) and ≥ 1.25 (25% or more increase), respectively. Reproducibility was confirmed by independent PCR repeated twice.
Mutation analysis of ING4
Mutation analysis was performed by RT-PCR and direct sequencing as described previously 2, 3) .
Results
Mapping of chromosome 12p12-13 region
By using homology search in genome database, we noticed the existence of a new member of ING family, ING4 gene at 12p13.31, in which frequent deletion has been reported in various cancers. To investigate the role of ING4 in head and neck cancers, we first redefined the mapping of 12p12-13 region by searching genome database and using contiguous sequences (http: // 322 
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Loss of heterozygosity analysis of chromosome 12p12-13 region
We selected 6 microsatellites markers on chromosome 12p12-13 to examine allelic loss in ING4 location.We analyzed DNAs from 50 pairs of matched HNSCC and normal tissues for losses at microsatellite markers D12S372, D12S825, D12S77, D12S1697, D12S89, and D12S391. Overall, LOH was detected at least one location in 33 of 50 (66%) samples. The most frequent loss (66%) was seen at marker D12S825, which is about 700 bps away from ING4 location. All these LOH data pointed out ING4 location as a hot target area in HNSCC.
Mutation analysis of ING4 gene
We examined all coding region of ING4 for mutation at RNA level by RT-PCR and direct sequencing in 50 HNSCC. However no somatic change was detected in any of the tumor samples.
ING4 mRNA expression analysis
We (Table 1) .
Discussion
Our studies involving ING1 and ING3 suggest that ING family is an important group of genes in the carcinogenic pathway of at least head and neck cancers. Recent progress in human sequencing displayed two new members of this family ING4 and ING5.
We did not detect any somatic mutation of ING4. Mutation analysis was performed at RNA level using cDNAs prepared from tumor samples and therefore mutant RNAs may not be stable and could be easily destroyed. However, decreased expression of ING4 was detected 76% of tumor samples as compared to their normal counterparts with quantitative real-time PCR. Most of those samples with low ING4 expression displayed extreme mRNA loss. 323
